250 related articles for article (PubMed ID: 20130129)
1. Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine.
Elberse KE; Tcherniaeva I; Berbers GA; Schouls LM
Clin Vaccine Immunol; 2010 Apr; 17(4):674-82. PubMed ID: 20130129
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.
Tan CY; Immermann FW; Sebastian S; Pride MW; Pavliakova D; Belanger KA; Watson W; Scott DA; Sidhu M; Jansen KU; Giardina PC
mSphere; 2018 Aug; 3(4):. PubMed ID: 30089644
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to
Pavliakova D; Giardina PC; Moghazeh S; Sebastian S; Koster M; Pavliak V; McKeen A; French R; Jansen KU; Pride M
mSphere; 2018 Aug; 3(4):. PubMed ID: 30089645
[TBL] [Abstract][Full Text] [Related]
4. Immune response to pneumococcal conjugate vaccination in asplenic individuals.
Stanford E; Print F; Falconer M; Lamden K; Ghebrehewet S; Phin N; Baxter D; Helbert M; McCann R; Andrews N; Balmer P; Borrow R; Kaczmarski E
Hum Vaccin; 2009 Feb; 5(2):85-91. PubMed ID: 18758242
[TBL] [Abstract][Full Text] [Related]
5. Impact of IgM Antibodies on Cross-Protection against Pneumococcal Serogroups 6 and 19 after Immunization with 7-Valent Pneumococcal Conjugate Vaccine in Children.
Cho HK; Park IH; Burton RL; Kim KH
J Korean Med Sci; 2016 Jun; 31(6):950-6. PubMed ID: 27247505
[TBL] [Abstract][Full Text] [Related]
6. Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.
Russell FM; Balloch A; Licciardi PV; Carapetis JR; Tikoduadua L; Waqatakirewa L; Cheung YB; Mulholland EK; Tang ML
Vaccine; 2011 Jun; 29(27):4499-506. PubMed ID: 21539882
[TBL] [Abstract][Full Text] [Related]
7. Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to measure serum antibodies against pneumococcal serotype-specific polysaccharides.
Feyssaguet M; Bellanger A; Nozay F; Friel D; Merck E; Verlant V; Malevé M; Lallemand S; El Moussaoui A; De Gorguette D'Argoeuves P; Jones T; Goldblatt D; Schoonbroodt S
Vaccine; 2019 Apr; 37(16):2208-2215. PubMed ID: 30879829
[TBL] [Abstract][Full Text] [Related]
8. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.
Simell B; Nurkka A; Ekström N; Givon-Lavi N; Käyhty H; Dagan R
Clin Vaccine Immunol; 2012 Oct; 19(10):1618-23. PubMed ID: 22875604
[TBL] [Abstract][Full Text] [Related]
9. Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.
Trück J; Thompson A; Morales-Aza B; Clutterbuck EA; Voysey M; Clarke E; Snape MD; Kelly DF; Finn A; Pollard AJ
Vaccine; 2017 May; 35(20):2701-2708. PubMed ID: 28392142
[TBL] [Abstract][Full Text] [Related]
10. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
[TBL] [Abstract][Full Text] [Related]
11. Responses to a conjugate pneumococcal vaccine in preterm infants immunized at 2, 3, and 4 months of age.
Moss SJ; Fenton AC; Toomey JA; Grainger AJ; Smith J; Gennery AR
Clin Vaccine Immunol; 2010 Nov; 17(11):1810-6. PubMed ID: 20861323
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
McFetridge R; Meulen AS; Folkerth SD; Hoekstra JA; Dallas M; Hoover PA; Marchese RD; Zacholski DM; Watson WJ; Stek JE; Hartzel JS; Musey LK
Vaccine; 2015 Jun; 33(24):2793-9. PubMed ID: 25913828
[TBL] [Abstract][Full Text] [Related]
13. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
[TBL] [Abstract][Full Text] [Related]
14. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.
Lee H; Nahm MH; Burton R; Kim KH
Clin Vaccine Immunol; 2009 Mar; 16(3):376-81. PubMed ID: 19144787
[TBL] [Abstract][Full Text] [Related]
15. The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early Infancy.
Trück J; Jawad S; Goldblatt D; Roalfe L; Snape MD; Voysey M; Pollard AJ
Pediatr Infect Dis J; 2016 Jul; 35(7):787-93. PubMed ID: 27088583
[TBL] [Abstract][Full Text] [Related]
16. Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.
van Westen E; Wijmenga-Monsuur AJ; van Dijken HH; van Gaans-van den Brink JA; Kuipers B; Knol MJ; Berbers GA; Sanders EA; Rots NY; van Els CA
Clin Infect Dis; 2015 Aug; 61(3):342-9. PubMed ID: 25838290
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
Carmona Martinez A; Prymula R; Miranda Valdivieso M; Otero Reigada MDC; Merino Arribas JM; Brzostek J; Szenborn L; Ruzkova R; Horn MR; Jackowska T; Centeno-Malfaz F; Traskine M; Dobbelaere K; Borys D
Vaccine; 2019 Jan; 37(1):176-186. PubMed ID: 30054160
[TBL] [Abstract][Full Text] [Related]
18. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
[TBL] [Abstract][Full Text] [Related]
19. Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children.
Dhooge IJ; van Kempen MJ; Sanders LA; Rijkers GT
Int J Pediatr Otorhinolaryngol; 2002 Jun; 64(2):133-41. PubMed ID: 12049826
[TBL] [Abstract][Full Text] [Related]
20. Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharides.
Whaley MJ; Rose C; Martinez J; Laher G; Sammons DL; Smith JP; Snawder JE; Borrow R; Biagini RE; Plikaytis B; Carlone GM; Romero-Steiner S
Clin Vaccine Immunol; 2010 May; 17(5):862-9. PubMed ID: 20335434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
